These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 17453748)

  • 1. Metabolic syndrome, organ damage and cardiovascular disease in treated hypertensive patients. The ERIC-HTA study.
    Navarro J; Redón J; Cea-Calvo L; Lozano JV; Fernández-Pérez C; Bonet A; González-Esteban J
    Blood Press; 2007; 16(1):20-7. PubMed ID: 17453748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kidney function and cardiovascular disease in the hypertensive population: the ERIC-HTA study.
    Redón J; Cea-Calvo L; Lozano JV; Fernández-Pérez C; Navarro J; Bonet A; González-Esteban J;
    J Hypertens; 2006 Apr; 24(4):663-9. PubMed ID: 16531794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Left ventricular hypertrophy in the Spanish hypertensive population. The ERIC-HTA study].
    Lozano JV; Redón J; Cea-Calvo L; Fernández-Pérez C; Navarro J; Bonet A; González-Esteban J
    Rev Esp Cardiol; 2006 Feb; 59(2):136-42. PubMed ID: 16540035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic syndrome in Portugal: prevalence and implications for cardiovascular risk--results from the VALSIM Study.
    Fiuza M; Cortez-Dias N; Martins S; Belo A;
    Rev Port Cardiol; 2008 Dec; 27(12):1495-529. PubMed ID: 19280993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age and target organ damage in essential hypertension: role of the metabolic syndrome.
    Cuspidi C; Meani S; Valerio C; Sala C; Fusi V; Zanchetti A; Mancia G
    Am J Hypertens; 2007 Mar; 20(3):296-303. PubMed ID: 17324743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of metabolic syndrome on hypertension-related target organ damage.
    Mulè G; Nardi E; Cottone S; Cusimano P; Volpe V; Piazza G; Mongiovì R; Mezzatesta G; Andronico G; Cerasola G
    J Intern Med; 2005 Jun; 257(6):503-13. PubMed ID: 15910554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. All-cause mortality risk predictors in a preventive cardiology clinic cohort-examining diabetes and individual metabolic syndrome criteria: a PRECIS database study.
    Doshi KB; Kashyap SR; Brennan DM; Hoar BM; Cho L; Hoogwerf BJ
    Diabetes Obes Metab; 2009 Feb; 11(2):102-8. PubMed ID: 18494803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clusters of metabolic risk factors predict cardiovascular events in hypertension with target-organ damage: the LIFE study.
    de Simone G; Olsen MH; Wachtell K; Hille DA; Dahlöf B; Ibsen H; Kjeldsen SE; Lyle PA; Devereux RB
    J Hum Hypertens; 2007 Aug; 21(8):625-32. PubMed ID: 17476291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic syndrome and ambulatory arterial stiffness index in non-diabetic patients with primary hypertension.
    Leoncini G; Ratto E; Viazzi F; Vaccaro V; Parodi A; Falqui V; Conti N; Tomolillo C; Deferrari G; Pontremoli R
    J Hum Hypertens; 2007 Oct; 21(10):802-7. PubMed ID: 17541383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of metabolic syndrome on risk stratification in hypertensive patients: differences between 2003 and 2007 ESH-ESC guidelines.
    Martell N; Alvarez-Alvarez B; Fernandez-Cruz A
    Ther Adv Cardiovasc Dis; 2010 Apr; 4(2):97-103. PubMed ID: 20200202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Target organ damage and cardiovascular complications in patients with hypertension and type 2 diabetes in Spain: a cross-sectional study.
    Cea-Calvo L; Conthe P; Gómez-Fernández P; de Alvaro F; Fernández-Pérez C;
    Cardiovasc Diabetol; 2006 Nov; 5():23. PubMed ID: 17083718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of metabolic syndrome on left ventricular mass in overweight and obese hypertensive subjects.
    Mulè G; Nardi E; Cottone S; Cusimano P; Incalcaterra F; Giandalia ME; Palermo A; Mezzatesta G; Cerasola G
    Int J Cardiol; 2007 Oct; 121(3):267-75. PubMed ID: 17258825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and correlates of advanced retinopathy in a large selected hypertensive population. The Evaluation of Target Organ Damage in Hypertension (ETODH) study.
    Cuspidi C; Meani S; Valerio C; Fusi V; Catini E; Sala C; Magrini F; Zanchetti A
    Blood Press; 2005; 14(1):25-31. PubMed ID: 15823944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Electrocardiographic criteria for left ventricular hypertrophy and cardiovascular risk in hypertensives. VIIDA study].
    González-Juanatey JR; Cea-Calvo L; Bertomeu V; Aznar J;
    Rev Esp Cardiol; 2007 Feb; 60(2):148-56. PubMed ID: 17338880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of left ventricular hypertrophy detected by Cornell voltage-duration product in a hypertensive population.
    Barrios V; Escobar C; Calderon A; Ribas L; Marti D; Asin E
    Blood Press; 2008; 17(2):110-5. PubMed ID: 18568700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. OMEGA study: design, baseline data, metabolic syndrome prevalence in a large-scale observational study of hypertensive patients: The Olmesartan Mega Study to Determine the Relationship between Cardiovascular Endpoints and Blood Pressure Goal Achievement study.
    Teramoto T; Fujita T; Kawamori R; Miyazaki S; Teramukai S; Igarashi M
    Hypertens Res; 2008 Nov; 31(11):2011-7. PubMed ID: 19098372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic syndrome determinants in an urban population from Brazil: social class and gender-specific interaction.
    Marquezine GF; Oliveira CM; Pereira AC; Krieger JE; Mill JG
    Int J Cardiol; 2008 Sep; 129(2):259-65. PubMed ID: 18036678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced levels of N-terminal-proatrial natriuretic peptide in hypertensive patients with metabolic syndrome and their relationship with left ventricular mass.
    Rubattu S; Sciarretta S; Ciavarella GM; Venturelli V; De Paolis P; Tocci G; De Biase L; Ferrucci A; Volpe M
    J Hypertens; 2007 Apr; 25(4):833-9. PubMed ID: 17351376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and correlates of metabolic syndrome (MS) in older adults.
    Cankurtaran M; Halil M; Yavuz BB; Dagli N; Oyan B; Ariogul S
    Arch Gerontol Geriatr; 2006; 42(1):35-45. PubMed ID: 16046242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microalbuminuria in patients with essential hypertension and its relationship to target organ damage: an Indian experience.
    Hitha B; Pappachan JM; Pillai HB; Sujathan P; Ramakrishna CD; Jayaprakash K; Raihanathul Misiriya KJ
    Saudi J Kidney Dis Transpl; 2008 May; 19(3):411-9. PubMed ID: 18445902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.